American Diabetes Association

The FDA named Dexcom the first participant in its TEMPO pilot on July 22, 2026, pairing real-world evidence collection with CMS's ACCESS payment model to support wearable diagnostic AI. Dexcom's devic…

UpDoc announced on June 25, 2026, that its AI platform received FDA clearance as the first FDA-cleared clinical AI agent and LLM-enabled device, though public records show the clearance (K253281) is f…